Showing results (141-150 of 608) with videos related to

Sort By:
Pageof 61
Journal of Medicinal Chemistry|January 6, 2006
Synthesis and antiviral evaluation of cyclic and acyclic 2-methyl-3-hydroxy-4-pyridinone nucleoside derivativesKarine Barral, Jan Balzarini, Johan Neyts, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2014
The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replicationAloys Tijsma, David Franco, Simon Tucker, et al.
The Journal of Antimicrobial Chemotherapy|June 23, 2012
Replication capacity of minority variants in viral populations can affect the assessment of resistance in HCV chimeric replicon phenotyping assaysThierry Verbinnen, Tom Jacobs, Leen Vijgen, et al.
Viruses|December 23, 2023
A Robust Phenotypic High-Throughput Antiviral Assay for the Discovery of Rabies Virus InhibitorsXinyu Wang, Winston Chiu, Hugo Klaassen, et al.
Antiviral Research|February 26, 2008
R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyondBert Thys, Armando M De Palma, Johan Neyts, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 4, 2021
Cytidine nucleoside analog is an effective antiviral drug against TrichomonasvirusRavi Kumar Narayanasamy, Petr Rada, Alois Zdrha, et al.
ACS Infectious Diseases|September 16, 2021
Assessing In Vitro Resistance Development in Enterovirus A71 in the Context of Combination Antiviral TreatmentKristina Lanko, Chenyan Shi, Shivaprasad Patil, et al.
Pageof 61